320 related articles for article (PubMed ID: 21252521)
21. Glomerular Immune Deposition in MPO-ANCA Associated Glomerulonephritis Is Associated With Poor Renal Survival.
Lin W; Shen C; Zhong Y; Ooi JD; Eggenhuizen P; Zhou YO; Luo H; Huang J; Chen JB; Wu T; Meng T; Xiao Z; Ao X; Peng W; Tang R; Yin H; Xiao X; Zhou Q; Xiao P
Front Immunol; 2021; 12():625672. PubMed ID: 33841408
[TBL] [Abstract][Full Text] [Related]
22. Transcription factor Nrf2 activation regulates NETosis, endothelial injury, and kidney disease in myeloperoxidase-positive antineutrophil cytoplasmic antibody-associated vasculitis.
Ueda Y; Nakazawa D; Nishio S; Shiratori-Aso S; Kudo T; Miyoshi-Harashima A; Watanabe-Kusunoki K; Hattanda F; Iwasaki S; Tsuji T; Tomaru U; Aratani Y; Yamamoto M; Ishizu A; Atsumi T
Kidney Int; 2024 Jun; 105(6):1291-1305. PubMed ID: 38537677
[TBL] [Abstract][Full Text] [Related]
23. Antineutrophil cytoplasmic autoantibodies and pathophysiology: new insights from animal models.
Huugen D; Tervaert JW; Heeringa P
Curr Opin Rheumatol; 2004 Jan; 16(1):4-8. PubMed ID: 14673382
[TBL] [Abstract][Full Text] [Related]
24. C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis.
Dick J; Gan PY; Ford SL; Odobasic D; Alikhan MA; Loosen SH; Hall P; Westhorpe CL; Li A; Ooi JD; Woodruff TM; Mackay CR; Kitching AR; Hickey MJ; Holdsworth SR
Kidney Int; 2018 Mar; 93(3):615-625. PubMed ID: 29241626
[TBL] [Abstract][Full Text] [Related]
25. Trafficking of QD-conjugated MPO-ANCA in murine systemic vasculitis and glomerulonephritis model mice.
Hoshino A; Nagao T; Ito-Ihara T; Ishida-Okawara A; Uno K; Muso E; Nagi-Miura N; Ohno N; Tokunaka K; Naoe S; Hashimoto H; Yasuhara M; Yamamoto K; Suzuki K
Microbiol Immunol; 2007; 51(5):551-66. PubMed ID: 17579266
[TBL] [Abstract][Full Text] [Related]
26. The role of neutrophils in causing antineutrophil cytoplasmic autoantibody-associated vasculitis.
Schreiber A; Choi M
Curr Opin Hematol; 2015 Jan; 22(1):60-6. PubMed ID: 25394311
[TBL] [Abstract][Full Text] [Related]
27. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis.
Schreiber A; Xiao H; Jennette JC; Schneider W; Luft FC; Kettritz R
J Am Soc Nephrol; 2009 Feb; 20(2):289-98. PubMed ID: 19073822
[TBL] [Abstract][Full Text] [Related]
28. Review article: Pathogenic role of complement activation in anti-neutrophil cytoplasmic auto-antibody-associated vasculitis.
Van Timmeren MM; Chen M; Heeringa P
Nephrology (Carlton); 2009 Feb; 14(1):16-25. PubMed ID: 19335841
[TBL] [Abstract][Full Text] [Related]
29. FcγRIIB regulates T-cell autoreactivity, ANCA production, and neutrophil activation to suppress anti-myeloperoxidase glomerulonephritis.
Ooi JD; Gan PY; Chen T; Eggenhuizen PJ; Chang J; Alikhan MA; Odobasic D; Holdsworth SR; Kitching AR
Kidney Int; 2014 Dec; 86(6):1140-9. PubMed ID: 24869670
[TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of ANCA-associated vasculitides.
Kallenberg CG
Ann Rheum Dis; 2011 Mar; 70 Suppl 1():i59-63. PubMed ID: 21339221
[TBL] [Abstract][Full Text] [Related]
31. Neutrophils from ANCA-associated vasculitis patients show an increased capacity to activate the complement system via the alternative pathway after ANCA stimulation.
Ohlsson S; Holm L; Hansson C; Ohlsson SM; Gunnarsson L; Pettersson Å; Skattum L
PLoS One; 2019; 14(6):e0218272. PubMed ID: 31216309
[TBL] [Abstract][Full Text] [Related]
32. The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis.
Schreiber A; Kettritz R
J Leukoc Biol; 2013 Oct; 94(4):623-31. PubMed ID: 23381471
[TBL] [Abstract][Full Text] [Related]
33. Myeloperoxidase-antineutrophil cytoplasmic antibody causes different renal diseases by immune-complex formation and pauci-immune mechanism: A case report.
Manabe S; Hatano M; Nakano M; Fujii T; Nitta K; Nagata M
Pathol Int; 2017 Aug; 67(8):419-424. PubMed ID: 28580649
[TBL] [Abstract][Full Text] [Related]
34. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
Tervaert JW; Heeringa P
Neth J Med; 2003 Dec; 61(12):404-7. PubMed ID: 15025415
[TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of ANCA-associated vasculitis, an update.
Kallenberg CG
Clin Rev Allergy Immunol; 2011 Oct; 41(2):224-31. PubMed ID: 21336557
[TBL] [Abstract][Full Text] [Related]
36. Overview of the Pathogenesis of ANCA-Associated Vasculitis.
Xiao H; Hu P; Falk RJ; Jennette JC
Kidney Dis (Basel); 2016 Mar; 1(4):205-15. PubMed ID: 27536680
[TBL] [Abstract][Full Text] [Related]
37. Genetically determined severity of anti-myeloperoxidase glomerulonephritis.
Xiao H; Ciavatta D; Aylor DL; Hu P; de Villena FP; Falk RJ; Jennette JC
Am J Pathol; 2013 Apr; 182(4):1219-26. PubMed ID: 23384999
[TBL] [Abstract][Full Text] [Related]
38. C5a receptor (CD88) blockade protects against MPO-ANCA GN.
Xiao H; Dairaghi DJ; Powers JP; Ertl LS; Baumgart T; Wang Y; Seitz LC; Penfold ME; Gan L; Hu P; Lu B; Gerard NP; Gerard C; Schall TJ; Jaen JC; Falk RJ; Jennette JC
J Am Soc Nephrol; 2014 Feb; 25(2):225-31. PubMed ID: 24179165
[TBL] [Abstract][Full Text] [Related]
39. B cell-mediated pathogenesis of ANCA-mediated vasculitis.
Jennette JC; Falk RJ
Semin Immunopathol; 2014 May; 36(3):327-38. PubMed ID: 24777746
[TBL] [Abstract][Full Text] [Related]
40. Antineutrophil cytoplasmic antibodies: major autoantigens, pathophysiology, and disease associations.
Schultz DR; Tozman EC
Semin Arthritis Rheum; 1995 Dec; 25(3):143-59. PubMed ID: 8650585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
